SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • August 23rd, 2024 • Evogene Ltd. • Agricultural chemicals • New York
Contract Type FiledAugust 23rd, 2024 Company Industry JurisdictionThis Securities Purchase Agreement (this “Agreement”) is dated as of August 23, 2024, between Evogene Ltd., a company organized under the laws of the State of Israel (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • January 31st, 2024 • Rail Vision Ltd. • Railroad equipment • New York
Contract Type FiledJanuary 31st, 2024 Company Industry JurisdictionThis Securities Purchase Agreement (this “Agreement”) is dated as of January [____], 2024, between Rail Vision Ltd., an Israeli company (the “Company”), and each purchaser identified on the signature pages hereto (including their respective successors and assigns, each a “Purchaser” and collectively, the “Purchasers”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • December 28th, 2023 • Meihua International Medical Technologies Co., Ltd. • Surgical & medical instruments & apparatus • New York
Contract Type FiledDecember 28th, 2023 Company Industry JurisdictionThis Securities Purchase Agreement (this “Agreement”) is dated as of December 27, 2023, by and between Meihua International Medical Technologies Co., Ltd., a Cayman Islands exempted company (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively, the “Purchasers”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • October 3rd, 2023 • Portage Biotech Inc. • Crude petroleum & natural gas • New York
Contract Type FiledOctober 3rd, 2023 Company Industry JurisdictionThis Securities Purchase Agreement (this “Agreement”) is dated as of September 29, 2023, between Portage Biotech Inc., a British Virgin Islands company (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • July 14th, 2023 • Digihost Technology Inc. • Finance services • New York
Contract Type FiledJuly 14th, 2023 Company Industry JurisdictionThis Securities Purchase Agreement (this “Agreement”) is dated as of March 6, 2022, between Digihost Technology Inc., a corporation incorporated under the British Columbia Business Corporations Act (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively, the “Purchasers”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • August 10th, 2021 • IceCure Medical Ltd. • Surgical & medical instruments & apparatus • New York
Contract Type FiledAugust 10th, 2021 Company Industry JurisdictionThis Securities Purchase Agreement (this “Agreement”) is dated as of January 26, 2021, between IceCure Medical Ltd., an Israeli corporation (the “Company”) and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively, the “Purchasers”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • August 6th, 2020 • Iterum Therapeutics PLC • Pharmaceutical preparations • New York
Contract Type FiledAugust 6th, 2020 Company Industry JurisdictionThis Securities Purchase Agreement (this “Agreement”) is dated as of June 3, 2020, between Iterum Therapeutics plc, an Irish incorporated public limited company (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • August 6th, 2020 • Iterum Therapeutics PLC • Pharmaceutical preparations • New York
Contract Type FiledAugust 6th, 2020 Company Industry JurisdictionThis Securities Purchase Agreement (this “Agreement”) is dated as of June 30, 2020, between Iterum Therapeutics plc, an Irish incorporated public limited company (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).